Alfredo Pennica

Alfredo Pennica

Auto-generated profile, based on publicly available information

Alfredo Pennica

Sapienza University of Rome, Rome Italy

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2020 in SN Comprehensive Clinical Medicine
Verified
Journal Article
Closed access
PDF file
APAlfredo Pennica
Alfredo Pennica
GCGiulia Conforti
Giulia Conforti
FFFrancesca Falangone
Francesca Falangone
AMAntonio Martocchia
Antonio Martocchia
LTLAURA TAFARO
LAURA TAFARO
PMPaolo Martelletti
Paolo Martelletti

16 June 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
GNGiuseppe Noce
Giuseppe Noce
CPClaudio Del Percio
Claudio Del Percio
PCPiervincenzi Claudia
Piervincenzi Claudia
FCFilippo Carducci
Filippo Carducci
RLRoberta Lizio
Roberta Lizio
Claudio BabiloniClaudio Babiloni
Claudio Babiloni
Background: This retrospective and exploratory study tested the concept that at the group level, human immunodeficiency virus (HIV) can significantly affect brain structure and function before the manifestation of significant cognitive deficits.Method: From a multicenter database, we selected structural 3T magnetic resonance imaging (MRI) and resting state eyes‐closed electroencephalographic (rsEEG) datasets in 30 HIV‐positive (HIV) subjects with relatively good cognitive status and serological markers (i.e., HIV‐RNA copies and CD4 count). Control datasets of matched non‐infected subjects included rsEEG (N = 50) and MRI (N = 30) recordings. MRI markers of interest in HIV were derived from gray matter (GM) volume decrements and white matter (WM) lesion load, while rsEEG markers were cortical source current density estimated by LORETA freeware at relevant delta (< 4 Hz) and alpha (6‐12 Hz) individual frequency bands.Result: In the HIV group, the subjects exhibited no abnormal score in neuropsychological tests. However, those subjects showed brain GM volume and WM abnormalities correlated with serum CD4 count (Figure 1). They also showed diffuse abnormalities in rsEEG alpha source activities.Conclusion: At the group level, HIV subjects with relatively good cognitive status can show abnormalities in both structural MRI and rsEEG markers. If cross‐validated in longitudinal studies, combined MRI and rsEEG markers may be a useful surrogate endpoint to test antiretroviral therapies with putative neuroprotective function.